Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 611

1.

The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.

Kassa J, Kuca K, Karasova J, Musilek K.

Mini Rev Med Chem. 2008 Oct;8(11):1134-43. Review.

PMID:
18855728
3.
5.
7.

A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.

Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.

J Enzyme Inhib Med Chem. 2010 Aug;25(4):480-4. doi: 10.3109/14756360903257918.

PMID:
20233085
8.

The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.

Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J.

J Appl Toxicol. 2010 Mar;30(2):120-4. doi: 10.1002/jat.1477.

PMID:
19746406
9.

A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.

Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.

J Enzyme Inhib Med Chem. 2009 Aug;24(4):1040-4. doi: 10.1080/14756360802608419.

PMID:
19552519
10.

A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.

Kassa J, Karasova JZ, Kuca K, Musilek K.

Drug Chem Toxicol. 2010 Jul;33(3):227-32. doi: 10.3109/01480540903483409.

PMID:
20429807
12.
14.

A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.

Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K.

J Enzyme Inhib Med Chem. 2008 Dec;23(6):776-80. doi: 10.1080/14756360701809902 .

PMID:
18608751
15.

The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.

Kassa J, Karasova J.

J Toxicol Environ Health A. 2007 Sep;70(18):1556-67.

PMID:
17710615
16.

A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.

Kassa J, Jun D, Karasova J, Bajgar J, Kuca K.

Chem Biol Interact. 2008 Sep 25;175(1-3):425-7. doi: 10.1016/j.cbi.2008.05.001. Epub 2008 May 4.

PMID:
18547554
18.

A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.

Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.

Toxicol Mech Methods. 2011 Mar;21(3):241-5. doi: 10.3109/15376516.2010.538750. Epub 2010 Dec 10.

PMID:
21142778
19.

Supplemental Content

Support Center